Literature DB >> 35373057

Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? CON.

Richard J Glassock1.   

Abstract

Entities:  

Keywords:  ANCA vasculitis; PLEX; clinical nephrology; diffuse alveolar hemorrhage; plasmapheresis

Mesh：

Year:  2021        PMID： 35373057      PMCID： PMC8791338          DOI： 10.34067/KID.0004102020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  9 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

3.  Therapeutic plasma exchange: complications and management.

Authors:  M H Mokrzycki; A A Kaplan
Journal:  Am J Kidney Dis       Date:  1994-06       Impact factor: 8.860

4.  Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes.

Authors:  Rodrigo Cartin-Ceba; Luis Diaz-Caballero; Mazen O Al-Qadi; Stavros Tryfon; Fernando C Fervenza; Steven R Ytterberg; Ulrich Specks
Journal:  Arthritis Rheumatol       Date:  2016-06       Impact factor: 10.995

5.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

Review 6.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

7.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Authors:  Michael Walsh; Alina Casian; Oliver Flossmann; Kerstin Westman; Peter Höglund; Charles Pusey; David R W Jayne
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

8.  The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition.

Authors:  J L Niles; E P Böttinger; G R Saurina; K J Kelly; G Pan; A B Collins; R T McCluskey
Journal:  Arch Intern Med       Date:  1996-02-26

9.  Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis.

Authors:  Frank B Cortazar; Saif A Muhsin; William F Pendergraft; Zachary S Wallace; Colleen Dunbar; Karen Laliberte; John L Niles
Journal:  Kidney Int Rep       Date:  2017-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.